GL1X · GenesisL1 explorer

Research workbench

Crystal Structure Anti-Oxycodone Antibody HY2-A12 Fab Complexed with Oxycodone

Analyse Crystal Structure Anti-Oxycodone Antibody HY2-A12 Fab Complexed with Oxycodone in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7U63
Type
protein
Length
1,258 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.3
Source
Mus musculus
Molecule
HY2-A12 Fab Light Chain; HY2-A12 Fab Heavy Chain
Ligands
OOX
Pockets
16 · best druggability 0.73

Structure

x-ray diffraction · resolution 2.3 · 3 distinct chains · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
L, A, CHY2-A12 Fab Light Chainprotein2098% helix, 55% strand—
HHY2-A12 Fab Heavy Chainprotein2016% helix, 53% strand—
B, DHY2-A12 Fab Heavy Chainprotein2156% helix, 51% strand—

Ligands and binding sites

  • OOX · 14-hydroxy-3-methoxy-17-methyl-5beta-4,5-epoxymorphinan-6-one · ligand · 3 copies · chains L, H, A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110210.730.7694empty
25410.650.7771empty
35930.640.7553empty
43610.550.7438empty
51770.450.7522empty

Interfaces

8 interfaces between chains.

  • C–D · 1839 Ų buried · 14 hydrogen bonds · protein-protein
  • L–H · 1813 Ų buried · 11 hydrogen bonds · protein-protein
  • A–B · 1799 Ų buried · 10 hydrogen bonds · protein-protein
  • H–A · 356 Ų buried · 8 hydrogen bonds · protein-protein
  • H–C · 268 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 disulfide (disulfide).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.